UroGen Pharma Ltd (URGN)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 16.6M | 16.1M | 18.09M | 17.19M | 21.14M | 20.85M | 23.53M | 18.78M |
Operating Income | -18.72M | -18.09M | -20.28M | -22.05M | -15.38M | -13.5M | -14.61M | -25.74M |
Pre Tax Income | -26.66M | -25.12M | -28.18M | -30.19M | -24.08M | -21.89M | -22.16M | -32.23M |
Net Income | -26.69M | -25.83M | -28.87M | -30.21M | -24.14M | -21.88M | -26.02M | -32.29M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -18.62M | -18.05M | -20.35M | -22.06M | -15.41M | -13.47M | -13.8M | -25.92M |
EBITDA | -18.48M | -17.85M | -20.05M | -21.83M | -15.17M | -13.31M | -14.42M | -25.62M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 17.53M | 8.16M | 1.13M | 18k | 11.8M | 48.04M | 64.36M | 82.71M |
Operating Income | 798k | -19.95M | -77.18M | -109.48M | -126.74M | -92.29M | -79.04M | -65.54M |
Pre Tax Income | -1.94M | -19.98M | -75.53M | -105.15M | -125.11M | -109.37M | -108.03M | -98.32M |
Net Income | -1.94M | -20M | -75.66M | -105.15M | -128.48M | -110.82M | -109.78M | -102.24M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.259 | -1.056 | -3.534 | -4.01 | -4.696 | -4.007 | -3.876 | -2.835 |
EBIT | 798k | -19.95M | -77.3M | -109.76M | -126.74M | -92.29M | -78.97M | -64.7M |
EBITDA | 1.01M | -19.74M | -76.76M | -109.18M | -126.32M | -91.46M | -78.12M | -64.73M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.